Crossmark

A radioiodinated FR-β-targeted tracer with improved pharmacokinetics through modification with an albumin binder for imaging of macrophages in AS and NAFL

Crossref DOI link: https://doi.org/10.1007/s00259-021-05447-4

Published Online: 2021-06-21

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wen, Xuejun

Shi, Changrong

Yang, Liu

Zeng, Xinying

Lin, Xiaoru

Huang, Jinxiong

Li, Yesen

Zhuang, Rongqiang

Zhu, Haibo

Guo, Zhide https://orcid.org/0000-0002-9110-159X
Zhang, Xianzhong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81901805)

National Natural Science Foundation of China (21976150)

Major Research Plan of the National Natural Science Foundation of China (91959122)

Joint Fund of the National Natural Science Foundation of China - China National Nuclear Corporation for Nuclear Technology Innovation (U1967222)
License Information

Text and Data Mining valid from 2021-06-21

Version of Record valid from 2021-06-21
More Information

Article History

Received: 4 March 2021

Accepted: 3 June 2021

First Online: 21 June 2021

Declarations

:

: Animal experiments were approved by the animal care committee of Xiamen University (ID XMULAC20190157) and carried out in compliance with the national laws related to the conduct of animal experimentation.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below